======= NME1-NME2 =======
== Gene Information ==
* **Official Symbol**: N/A
* **Official Name**: N/A
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: N/A
* **UniProt**: N/A
* **Interactions**: [[https://thebiogrid.org/search.php?search=NME1-NME2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NME1-NME2|Open PubMed]]
* **OMIM**: N/A
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Major role in the synthesis of nucleoside triphosphates other than ATP. Negatively regulates Rho activity by interacting with AKAP13/LBC. Acts as a transcriptional activator of the MYC gene; binds DNA non-specifically (PubMed:8392752). Exhibits histidine protein kinase activity. {ECO:0000269|PubMed:15249197, ECO:0000269|PubMed:20946858, ECO:0000269|PubMed:8392752}.
|NDK|
No GO term information is available for this gene.
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp38|Wortmannin 5μM R00 exp38]]|-2.35|
|[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|-1.87|
|[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|-1.78|
|[[:results:exp58|UM131593 0.1μM R01 exp58]]|-1.75|
|[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.72|
|[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-1.7|
|[[:results:exp217|Mdivi-1 15μM R05 exp217]]|1.7|
|[[:results:exp443|SNS-032 15μM R08 exp443]]|1.73|
|[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|1.89|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: N/A
^Tissue^Fraction Of Cell Lines Where Essential^
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13807
* **Expression level (log2 read counts)**: 7.27
{{:chemogenomics:nalm6 dist.png?nolink |}}